Hickman noted that a single dose of CYB003 has led to a 12-13 point ... “the need for frequent re-dosing seen with JNJ's Spravato." He argued that the commercial success of JNJ's ketamine ...

Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...

Enter psychedelics like ketamine, psilocybin, and MDMA, which are being explored as tools to access and process these buried ...

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" under medical supervision and has a prescription from "an actual, real doctor." ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

They could also be cheaper, given that Spravato's US list price in the US is $590 to $885 for two doses. “Use of an extended-release oral dosage ketamine formulation may be advantageous compared ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on earnings, an EDC system ...

In 2019, esketamine (Spravato), derived from ketamine, was approved by the FDA as a nasal spray for treatment-resistant depression. While ketamine therapy has shown promising results, its use ...

Spravato (esketamine ... not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive episode. It is estimated that approximately ...